Return to homepagePandemic Pact

In vitro assessment of the sensitivity of SARS-CoV-2 501Y.V2, a novel lineage circulating in South Africa, to convalescent and vaccine sera - pilot study

  • Funded by Department of Science and Innovation - South Africa
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $152,940.27

  • Funder

    Department of Science and Innovation - South Africa

  • Principal Investigator

    N/A

  • Research Location

    South Africa

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract